Edge Wealth Management’s NanoViricides NNVC Stock Holding History

Edge Wealth Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200	Closed	-$1K	–	568
2020 Q2	$1K	Buy	+200	New	+$1.39K	﹤0.01%	640

Other funds holding NNVC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HIS

Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edge Wealth Management's NNVC Position: Q3 2020 in Review

Edge Wealth Management sold out of NanoViricides (NNVC) in Q3 2020, closing a stake of 200 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in NNVC in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 36 funds tracked by Wall St. Rank hold NNVC as of Q3 2020.

Edge Wealth Management reported no remaining NanoViricides position as of Q3 2020 after selling out during the quarter.
Edge Wealth Management sold 200 NanoViricides shares in Q3 2020, an estimated $1K.
Edge Wealth Management first reported a position in NanoViricides in Q2 2020 and held it in 1 quarter.
Edge Wealth Management's NanoViricides position peaked at $1K in Q2 2020.
36 funds tracked by Wall St. Rank held NanoViricides as of Q3 2020.

Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.